We are live on ! Find out more
BRTX icon

BioRestorative Therapies
BRTX

13 hedge funds and large institutions have $606K invested in BioRestorative Therapies in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 12 → 13 (+1)

0.65% less ownership

Funds ownership: 7.91% → 7.26% (-0.65%)

55% less capital invested

Capital invested by funds: $1.36M → $606K (-$751K)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCM
Lynwood Capital Management
Ontario, Canada
+$50.4K
2
FIA
FNY Investment Advisers
New York
+$37K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$27.4K
4
Osaic Holdings
Osaic Holdings
Arizona
+$756
5
JP Morgan Chase
JP Morgan Chase
New York
+$10

Top Sellers

Rank Fund Capital Flow
1
WA
Wealth Alliance
New York
-$10.9K
2
SPIA
Steward Partners Investment Advisory
New York
-$8.82K
3
UBS Group
UBS Group
Switzerland
-$7.76K
4
Wells Fargo
Wells Fargo
California
-$5.59K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$4.29K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$247K +$27.4K +10,862 +9%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$77K -$1.26K -498 -1%
WA
3
Wealth Alliance
New York
$71.6K -$10.9K -4,316 -10%
Mariner
4
Mariner
Kansas
$47.7K – – –
Two Sigma Advisers
5
Two Sigma Advisers
New York
$44K -$4.29K -1,700 -6%
State Street
6
State Street
Massachusetts
$36.4K – – –
LCM
7
Lynwood Capital Management
Ontario, Canada
$35.8K +$50.4K +20,000 New
FIA
8
FNY Investment Advisers
New York
$26K +$37K +14,665 New
Wells Fargo
9
Wells Fargo
California
$16.7K -$5.59K -2,217 -19%
Osaic Holdings
10
Osaic Holdings
Arizona
$3.93K +$756 +300 +16%
JP Morgan Chase
11
JP Morgan Chase
New York
$7 +$10 +4 New
UBS Group
12
UBS Group
Switzerland
$2 -$7.76K -3,078 -100%
CPG
13
Cornerstone Planning Group
New Jersey
$2 +$3 +1 New
SPIA
14
Steward Partners Investment Advisory
New York
– -$8.82K -2,000 Closed
TRCT
15
Tower Research Capital (TRC)
New York
– -$3.26K -740 Closed
JWM
16
Janiczek Wealth Management
Colorado
– -$5 -1 Closed

BRTX Hedge Fund Activity: Q3 2023 in Review

13 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q3 2023, worth a combined $606K — down 55% from $1.36M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BRTX positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Lynwood Capital Management, opening a new position worth an estimated $50.4K. The largest seller was Wealth Alliance, cutting an estimated $10.9K.

  • 13 institutional investors held BioRestorative Therapies (BRTX) as of Q3 2023, up from 12 in Q2 2023.
  • Funds reported $606K of BioRestorative Therapies stock for Q3 2023, down 55% quarter-over-quarter.
  • 4 funds opened new BioRestorative Therapies positions in Q3 2023 and 3 closed out, a net change of +1 holder.
  • The largest BioRestorative Therapies buyer in Q3 2023 was Lynwood Capital Management, an estimated $50.4K added.
  • The largest BioRestorative Therapies seller in Q3 2023 was Wealth Alliance, an estimated $10.9K sold.

Based on aggregated 13F filings for Q3 2023.